Curr Diab Rep

Type 2 diabetes is a major public health problem in the USA, affecting over 12\uc2\ua0% of American adults and imposing considerable health and economic burden on individuals and society. There is a strong evidence base demonstrating that lifestyle behavioral changes and some medications can prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual framework for organizing how the ACA may influence diabetes prevention efforts at the level of individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity areas for future research and action.K23 DK095981/DK/NIDDK NIH HHS/United StatesP30 DK092949/DK/NIDDK NIH HHS/United StatesU58 DP002718/DP/NCCDPHP CDC HHS/United StatesUL1 TR001422/TR/NCATS NIH HHS/United States2017-06-01T00:00:00Z27145778PMC521017